Quarterly report pursuant to Section 13 or 15(d)

Operating Segments (Tables)

Operating Segments (Tables)

6 Months Ended

Jun. 30, 2020

Schedule of Segment Reporting Information

The table below presents certain financial information of our operating segments for the three and six months ended June 30, 2020 and 2019 (in thousands):

Segment Reporting for the Quarter Ended June 30, 2020

	Treatment			Services			Medical			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	7,840		$	14,207			—		$	22,047		$	—		$	22,047
Intercompany revenues		446			5			—			451			—			—
Gross profit		1,695			1,615			—			3,310			—			3,310
Research and development		52			46			74			172			37			209
Interest income		1			—			—			1			27			28
Interest expense		(28	)		(4	)		—			(32	)		(67	)		(99	)
Interest expense-financing fees		—			—			—			—			(60	)		(60	)
Depreciation and amortization		275			84			—			359			5			364
Segment income (loss) before income taxes		750			1,031			(74	)		1,707			(1,456	)		251
Income tax benefit		(9	)		—			—			(9	)		—			(9	)
Segment income (loss)		759			1,031			(74	)		1,716			(1,456	)		260
Expenditures for segment assets		320			146			—			466			2			⁴⁶⁸	⁽³⁾

Segment Reporting for the Quarter Ended June 30, 2019

	Treatment			Services			Medical			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	10,094		$	7,041			—		$	17,135		$	—		$	17,135
Intercompany revenues		7			42			—			49			—			—
Gross profit		2,627			644			—			3,271			—			3,271
Research and development		136			—			80			216			7			223
Interest income		—			—			—			—			107			107
Interest expense		(30	)		(4	)		—			(34	)		(73	)		(107	)
Interest expense-financing fees		—			—			—			—			(60	)		(60	)
Depreciation and amortization		233			79			—			312			5			317
Segment income (loss) before income taxes		1,611			137			(80	)		1,668			(1,289	)		379
Income tax expense		6			—			—			6			—			6
Segment income (loss)		1,605			137			(80	)		1,662			(1,289	)		373
Expenditures for segment assets		73			15			—			88			—			88	⁽²⁾

Segment Reporting for the Six Months Ended June 30, 2020

	Treatment			Services			Medical			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	17,403		$	29,504			—		$	46,907		$	—		$	46,907
Intercompany revenues		653			13			—			666			—			—
Gross profit		4,440			3,510			—			7,950			—			7,950
Research and development		145			112			140			397			44			441
Interest income		1			—			—			1			83			84
Interest expense		(46	)		(10	)		—			(56	)		(163	)		(219	)
Interest expense-financing fees		—			—			—			—			(129	)		(129	)
Depreciation and amortization		539			162			—			701			10			711
Segment income (loss) before income taxes		2,297			2,349			(140	)		4,506			(2,933	)		1,573
Income tax expense		5			—			—			5			—			5
Segment income (loss)		2,292			2,349			(140	)		4,501			(2,933	)		1,568
Expenditures for segment assets		1,000			361			—			1,361			5			1,366	⁽³⁾

Segment Reporting for the Six Months Ended June 30, 2019

	Treatment			Services			Medical			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	19,999		$	8,844			—		$	28,843		$	—		$	28,843
Intercompany revenues		9			63			—			72			—			—
Gross profit		5,584			188			—			5,772			—			5,772
Research and development		283			—			154			437			13			450
Interest income		—			—			—			—			188			188
Interest expense		(47	)		(13	)		—			(60	)		(134	)		(194	)
Interest expense-financing fees		—			—			—			—			(70	)		(70	)
Depreciation and amortization		470			157			—			627			14			641
Segment income (loss) before income taxes		3,487			(875	)		(154	)		2,458			(2,590	)		(132	)
Income tax expense		45			—			—			45			—			45
Segment income (loss)		3,442			(875	)		(154	)		2,413			(2,590	)		(177	)
Expenditures for segment assets		294			18			—			312			—			312	⁽²⁾

⁽¹⁾Amounts reflect the activity for corporate headquarters not included in the segment information.

⁽²⁾Net of financed amount of $18,000 and $22,000 for the three and six months ended June 30, 2019, respectively.

⁽³⁾Net of financed amount of $51,000 and $132,000 for the three and six months ended June 30, 2020, respectively.